Public Health | November 30, 2021
Covishield effectiveness during the second wave at 63 per cent
Vaccine effectiveness of complete vaccination against the moderate-to-severe disease was at 81 per cent
Vaccine effectiveness of complete vaccination against the moderate-to-severe disease was at 81 per cent
Booster dose is available to all residents aged 18+ and can be applied six months after the second dose of any other vaccine administered in UAE
Applications supported by positive results from the pivotal Phase 3 POETYK-PSO clinical trial program demonstrating superior efficacy of deucravacitinib over Otezla (apremilast)
ALASTIN’s patented, differentiated technology and products are highly synergistic with Galderma’s premium portfolio
It is the first targeted fluorescent imaging agent that illuminates ovarian cancer intraoperatively, enabling the detection of more cancer for removal
Researchers observed that the Pfizer/BioNTech and Moderna vaccines were 78% and 73% effective in preventing Covid-19 infections, respectively
This collaborative nursing conference generated a positive dialogue on how the healthcare space of nursing has evolved in the past year
Sciflix is a special Initiative by Lupin to assist future pulmonologists in staying abreast of the latest medical advances relevant to their speciality
The Omicron variant doesn't escape RTPCR and RAT; States advised to ramp up testing for prompt and early identification of any cases
Growing CRISPR genome editing portfolio supports researchers on path to future therapeutic applications
Subscribe To Our Newsletter & Stay Updated
